Position in GILD
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$14,260,627
-$1,750,198 QoQ
Shares Held
112,875
-1.7% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
1.10%
of 13F equity value
Holder Rank
#375
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Stonebridge Capital Advisors LLC holds $79,452,749 across 7 Drug Manufacturers - General names. GILD ranks #3 (17.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
86,589 | $21,991,008 | |
| 2 | MRK |
Merck & Co., Inc.
|
148,656 | $19,102,296 | |
| 3 | GILD |
Gilead Sciences, Inc.
This page
|
112,875 | $14,260,627 | |
| 4 | LLY |
ELI LILLY & Co
|
11,574 | $13,882,203 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
162,082 | $9,339,164 | |
| 6 | PFE |
Pfizer Inc
|
20,095 | $483,887 | |
| 7 | ABBV |
AbbVie Inc.
|
1,564 | $393,564 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,260,627 | 112,875 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $16,010,825 | 114,880 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $14,941,999 | 121,737 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $14,438,991 | 130,081 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $15,423,125 | 139,110 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $16,477,176 | 147,052 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $17,935,852 | 194,174 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $11,705,405 | 139,616 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $9,253,019 | 134,864 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $9,331,903 | 127,398 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $9,570,116 | 118,135 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $8,504,640 | 113,486 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $8,483,326 | 110,073 | Shares | Sole | 2023-08-23 | |
| 2023-03-31 | $8,540,682 | 102,937 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $8,517,092 | 99,209 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $5,945,558 | 96,378 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,984,135 | 96,815 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $6,060,273 | 101,939 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $7,396,054 | 101,860 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $7,103,535 | 101,697 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $6,423,742 | 93,287 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $6,029,138 | 93,287 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $5,916,128 | 101,547 | Shares | Sole | 2021-03-05 | |
| 2020-09-30 | $6,259,222 | 99,054 | Shares | Sole | 2020-11-18 | |
| 2020-06-30 | $7,675,226 | 99,756 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $7,645,630 | 102,269 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||